MSc Civil Engineering and Management
The MSc Civil Engineering and Management program at the University of Nottingham aim to...
University Park Campus
INTAKE: September
The MSc Cancer Immunology and Biotechnology program offered by the University of Nottingham is an advanced pathway tailored to empower students with the knowledge and skills needed to navigate the cutting-edge fields of cancer immunology and biotechnology. This interdisciplinary program focuses on harnessing the potential of the immune system to combat cancer and explores the applications of biotechnology in cancer research and therapy.
Comprehensive Curriculum: The MSc Cancer Immunology and Biotechnology program provide a comprehensive curriculum encompassing fundamental aspects of cancer biology, immunology, and biotechnology. Students gain a deep understanding of the interaction between the immune system and cancer cells.
Innovative Research: The program offers opportunities to engage in innovative research projects focused on cancer immunology and biotechnology. Students work with experts in the field, contributing to advancements in cancer treatment and therapy.
Cutting-edge Techniques: Students gain hands-on experience with cutting-edge techniques used in cancer research, including immunotherapy, molecular biology, genomics, and bioinformatics.
Translational Approach: The program emphasizes the translational aspect of research, enabling students to bridge the gap between laboratory discoveries and clinical applications, thus contributing to the development of effective cancer treatments.
Industry Collaboration: With strong industry connections, students have the chance to collaborate on real-world projects, internships, and placements. This exposure enhances their understanding of practical applications and potential career paths.
University Park Campus
IELTS 6.5
£ 30200
Postgraduate Entry Requirements: For admission into postgraduate programs at the University of Nottingham, international students are generally required to meet the following criteria:
Academic Qualifications: Students should have completed a bachelor's degree or its equivalent with a minimum of 60% or above in their country's grading system. The specific entry requirements may vary depending on the chosen program of study. Some programs may have additional subject-specific requirements or prerequisite knowledge.
Students must provide:
Work experience: Some postgraduate courses may require relevant work experience in the field.
It is important to note that meeting the minimum entry requirements does not guarantee admission, as the university considers factors such as availability of places and competition for the program. Additionally, some courses may have higher entry requirements or additional selection criteria, such as interviews or portfolio submissions.
Scholarships for International Students at the University of Nottingham:
It's important to note that scholarship availability, eligibility criteria, and application deadlines may vary from year to year.
Graduates of the MSc Cancer Immunology and Biotechnology program from the University of Nottingham are well-prepared to pursue a variety of impactful career paths.
Cancer Immunologist: Graduates can work as cancer immunologists, conducting research to understand the immune response to cancer and developing novel immunotherapies.
Biotechnology Researcher: Equipped with skills in biotechnology, graduates can contribute to research and development in biotech companies, focusing on cancer diagnostics, drug development, and therapeutic innovations.
Clinical Research Coordinator: Graduates can work in clinical research roles, coordinating trials and studies focused on testing new cancer treatments and therapies.
Academic Researcher: Many graduates choose to pursue further academic research, enrolling in Ph.D. programs to delve deeper into cancer immunology and contribute to scientific advancements.
Biomedical Consultant: With expertise in both cancer immunology and biotechnology, graduates can work as consultants, advising healthcare organizations and biotech firms on innovative approaches to cancer treatment.